| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Chikungunya virus | 14 | 2022 | 339 | 3.93 | Why? |
| Chikungunya Fever | 12 | 2022 | 345 | 3.50 | Why? |
| Alphavirus Infections | 4 | 2018 | 68 | 2.45 | Why? |
| Alphavirus | 4 | 2018 | 90 | 2.16 | Why? |
| Zika Virus Infection | 12 | 2018 | 1920 | 2.16 | Why? |
| Zika Virus | 10 | 2018 | 1924 | 1.68 | Why? |
| Aedes | 3 | 2022 | 380 | 1.31 | Why? |
| Arthralgia | 2 | 2018 | 173 | 1.19 | Why? |
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 2020 | 102 | 0.81 | Why? |
| Poisons | 1 | 2018 | 26 | 0.74 | Why? |
| Monocytes | 4 | 2021 | 2978 | 0.73 | Why? |
| Gene Deletion | 1 | 2020 | 430 | 0.73 | Why? |
| Plasmodium | 1 | 2018 | 74 | 0.71 | Why? |
| Culex | 1 | 2018 | 66 | 0.70 | Why? |
| Callithrix | 1 | 2018 | 288 | 0.66 | Why? |
| Hepatocyte Growth Factor | 1 | 2016 | 71 | 0.64 | Why? |
| Matrix Metalloproteinases | 1 | 2016 | 131 | 0.61 | Why? |
| Fingolimod Hydrochloride | 1 | 2017 | 217 | 0.58 | Why? |
| Dengue Virus | 3 | 2017 | 910 | 0.58 | Why? |
| Capillary Permeability | 1 | 2016 | 277 | 0.56 | Why? |
| Singapore | 10 | 2021 | 3641 | 0.55 | Why? |
| Microglia | 1 | 2017 | 357 | 0.52 | Why? |
| Chemokine CXCL10 | 1 | 2016 | 565 | 0.47 | Why? |
| Macrophages | 4 | 2018 | 2784 | 0.47 | Why? |
| Killer Cells, Natural | 2 | 2018 | 2093 | 0.44 | Why? |
| Epitopes | 2 | 2020 | 4113 | 0.41 | Why? |
| Antibodies, Neutralizing | 7 | 2021 | 25288 | 0.41 | Why? |
| Virus Replication | 10 | 2022 | 14331 | 0.40 | Why? |
| Cytokines | 9 | 2021 | 15010 | 0.40 | Why? |
| Mice, Knockout | 4 | 2018 | 1815 | 0.39 | Why? |
| Carrier State | 1 | 2021 | 2100 | 0.38 | Why? |
| CD8-Positive T-Lymphocytes | 4 | 2020 | 5837 | 0.38 | Why? |
| Malaria | 1 | 2018 | 1097 | 0.36 | Why? |
| Plasmodium berghei | 2 | 2018 | 27 | 0.36 | Why? |
| B-Lymphocytes | 2 | 2020 | 4418 | 0.36 | Why? |
| Malaria, Cerebral | 2 | 2018 | 37 | 0.35 | Why? |
| Animals | 25 | 2022 | 78931 | 0.35 | Why? |
| Coinfection | 5 | 2020 | 6820 | 0.35 | Why? |
| Nucleocapsid Proteins | 1 | 2020 | 3120 | 0.35 | Why? |
| Neutrophils | 2 | 2021 | 5476 | 0.33 | Why? |
| Immunoassay | 2 | 2020 | 4485 | 0.33 | Why? |
| Antibodies, Viral | 11 | 2021 | 51949 | 0.33 | Why? |
| Mice, Inbred C57BL | 7 | 2018 | 5542 | 0.32 | Why? |
| Guillain-Barre Syndrome | 1 | 2018 | 1495 | 0.29 | Why? |
| CD4-Positive T-Lymphocytes | 2 | 2018 | 4545 | 0.29 | Why? |
| Antiviral Agents | 7 | 2021 | 41703 | 0.29 | Why? |
| Spike Glycoprotein, Coronavirus | 7 | 2021 | 37182 | 0.28 | Why? |
| Dengue | 2 | 2017 | 1565 | 0.28 | Why? |
| Drug Discovery | 2 | 2018 | 3092 | 0.27 | Why? |
| Genome, Viral | 4 | 2020 | 13157 | 0.27 | Why? |
| Viremia | 2 | 2018 | 1020 | 0.27 | Why? |
| Flow Cytometry | 3 | 2021 | 2393 | 0.26 | Why? |
| Viral Load | 9 | 2021 | 15850 | 0.26 | Why? |
| Brain-Derived Neurotrophic Factor | 2 | 2021 | 133 | 0.26 | Why? |
| Interferon-gamma | 3 | 2018 | 2711 | 0.26 | Why? |
| Antigens, Viral | 2 | 2020 | 6298 | 0.26 | Why? |
| Cells, Cultured | 4 | 2018 | 5835 | 0.25 | Why? |
| Disease Outbreaks | 9 | 2020 | 27595 | 0.25 | Why? |
| Influenza A Virus, H5N1 Subtype | 1 | 2006 | 492 | 0.23 | Why? |
| Vascular Endothelial Growth Factor D | 1 | 2021 | 38 | 0.23 | Why? |
| Adaptive Immunity | 3 | 2018 | 2585 | 0.23 | Why? |
| Saliva | 1 | 2018 | 4679 | 0.23 | Why? |
| Lymphocyte Activation | 3 | 2021 | 2742 | 0.22 | Why? |
| Nervous System Malformations | 2 | 2017 | 43 | 0.22 | Why? |
| Aging | 1 | 2017 | 3581 | 0.21 | Why? |
| Immunoglobulin Class Switching | 1 | 2021 | 133 | 0.21 | Why? |
| Humans | 54 | 2022 | 930598 | 0.21 | Why? |
| RNA, Viral | 8 | 2018 | 32276 | 0.21 | Why? |
| Viral Vaccines | 2 | 2020 | 7560 | 0.20 | Why? |
| Viral Nonstructural Proteins | 1 | 2018 | 4810 | 0.20 | Why? |
| Endothelium, Vascular | 2 | 2021 | 1751 | 0.19 | Why? |
| Polyproteins | 1 | 2002 | 814 | 0.19 | Why? |
| Steroid 12-alpha-Hydroxylase | 1 | 2018 | 1 | 0.19 | Why? |
| Lysosomal-Associated Membrane Protein 1 | 1 | 2018 | 27 | 0.19 | Why? |
| Mosquito Vectors | 1 | 2022 | 351 | 0.18 | Why? |
| Interferon Regulatory Factor-1 | 1 | 2018 | 33 | 0.18 | Why? |
| Immunologic Tests | 2 | 2021 | 445 | 0.18 | Why? |
| Severity of Illness Index | 5 | 2021 | 48226 | 0.18 | Why? |
| Indian Ocean Islands | 1 | 2017 | 31 | 0.18 | Why? |
| West Indies | 1 | 2017 | 48 | 0.18 | Why? |
| Ribonucleotides | 1 | 2018 | 96 | 0.18 | Why? |
| Immunoglobulin G | 4 | 2021 | 21571 | 0.17 | Why? |
| Coronavirus Infections | 7 | 2020 | 253789 | 0.17 | Why? |
| Receptors, CXCR3 | 1 | 2018 | 159 | 0.17 | Why? |
| Phorbol Esters | 1 | 2016 | 14 | 0.17 | Why? |
| Mice | 7 | 2018 | 21357 | 0.17 | Why? |
| Bile Acids and Salts | 1 | 2018 | 91 | 0.17 | Why? |
| Receptors, Tumor Necrosis Factor | 1 | 2016 | 40 | 0.17 | Why? |
| Protein Kinase C | 1 | 2016 | 58 | 0.17 | Why? |
| Pyrroles | 2 | 2017 | 292 | 0.17 | Why? |
| Models, Animal | 2 | 2017 | 788 | 0.17 | Why? |
| Cell Membrane | 1 | 2002 | 743 | 0.16 | Why? |
| Complement System Proteins | 1 | 2020 | 380 | 0.16 | Why? |
| Vascular Cell Adhesion Molecule-1 | 1 | 2016 | 121 | 0.16 | Why? |
| Leukocytes, Mononuclear | 2 | 2017 | 2115 | 0.16 | Why? |
| Matrix Metalloproteinase 2 | 1 | 2016 | 85 | 0.16 | Why? |
| Lymphocyte Depletion | 1 | 2018 | 293 | 0.16 | Why? |
| Transcriptome | 2 | 2021 | 3466 | 0.16 | Why? |
| Pneumonia, Viral | 7 | 2021 | 243684 | 0.16 | Why? |
| Biomarkers | 5 | 2021 | 23361 | 0.16 | Why? |
| Lipopolysaccharides | 1 | 2020 | 848 | 0.15 | Why? |
| Th17 Cells | 1 | 2021 | 657 | 0.15 | Why? |
| Immunophenotyping | 1 | 2020 | 1290 | 0.15 | Why? |
| SARS Virus | 5 | 2009 | 13021 | 0.15 | Why? |
| Matrix Metalloproteinase 9 | 1 | 2016 | 211 | 0.15 | Why? |
| Gram-Negative Bacterial Infections | 1 | 2020 | 398 | 0.15 | Why? |
| Immunodominant Epitopes | 1 | 2020 | 813 | 0.15 | Why? |
| Immunity, Innate | 3 | 2018 | 6570 | 0.15 | Why? |
| Microcephaly | 1 | 2017 | 181 | 0.14 | Why? |
| Models, Immunological | 1 | 2020 | 727 | 0.14 | Why? |
| Severe Dengue | 1 | 2016 | 135 | 0.14 | Why? |
| Genome, Human | 1 | 2018 | 400 | 0.14 | Why? |
| Arthritis | 1 | 2018 | 288 | 0.14 | Why? |
| Infectious bronchitis virus | 1 | 2002 | 856 | 0.14 | Why? |
| Open Reading Frames | 2 | 2020 | 1898 | 0.14 | Why? |
| Primates | 1 | 2017 | 584 | 0.14 | Why? |
| Serogroup | 1 | 2016 | 510 | 0.13 | Why? |
| Amino Acid Sequence | 4 | 2020 | 6049 | 0.13 | Why? |
| Receptors, IgG | 1 | 2018 | 578 | 0.13 | Why? |
| Disease Models, Animal | 5 | 2018 | 10998 | 0.13 | Why? |
| Necrosis | 1 | 2017 | 532 | 0.13 | Why? |
| Cell Line | 3 | 2018 | 12040 | 0.13 | Why? |
| Tears | 1 | 2017 | 400 | 0.13 | Why? |
| Macaca fascicularis | 1 | 2018 | 1009 | 0.13 | Why? |
| Interleukin-10 | 1 | 2020 | 1409 | 0.13 | Why? |
| Fetus | 1 | 2017 | 484 | 0.13 | Why? |
| Respiratory Therapy | 1 | 2020 | 918 | 0.13 | Why? |
| Up-Regulation | 1 | 2021 | 2249 | 0.12 | Why? |
| Vero Cells | 6 | 2017 | 14117 | 0.12 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.12 | Why? |
| Polymerase Chain Reaction | 3 | 2005 | 6740 | 0.12 | Why? |
| Kidney Diseases | 2 | 2021 | 1434 | 0.12 | Why? |
| Encephalitis, Viral | 1 | 2017 | 355 | 0.12 | Why? |
| NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2017 | 581 | 0.12 | Why? |
| Epitopes, B-Lymphocyte | 1 | 2020 | 1267 | 0.12 | Why? |
| Brain | 3 | 2018 | 5133 | 0.11 | Why? |
| Middle Aged | 15 | 2021 | 270681 | 0.11 | Why? |
| Adult | 14 | 2021 | 244371 | 0.11 | Why? |
| Inflammation | 3 | 2020 | 13255 | 0.11 | Why? |
| Cross Reactions | 2 | 2017 | 4374 | 0.11 | Why? |
| Inflammasomes | 1 | 2017 | 710 | 0.11 | Why? |
| T-Lymphocyte Subsets | 1 | 2018 | 1387 | 0.10 | Why? |
| Disease Reservoirs | 1 | 2020 | 1672 | 0.10 | Why? |
| Betacoronavirus | 5 | 2020 | 204454 | 0.10 | Why? |
| Coronavirus | 1 | 2020 | 18339 | 0.10 | Why? |
| Proteins | 1 | 2018 | 921 | 0.10 | Why? |
| HEK293 Cells | 3 | 2018 | 8394 | 0.10 | Why? |
| Male | 18 | 2021 | 367725 | 0.10 | Why? |
| Peptides | 1 | 2002 | 2513 | 0.10 | Why? |
| Longitudinal Studies | 2 | 2018 | 9893 | 0.10 | Why? |
| Female | 18 | 2021 | 380317 | 0.10 | Why? |
| Mice, Transgenic | 1 | 2017 | 2739 | 0.10 | Why? |
| Skin | 2 | 2018 | 2096 | 0.09 | Why? |
| Diabetes Complications | 1 | 2021 | 2358 | 0.09 | Why? |
| Hypoxia | 2 | 2021 | 3626 | 0.09 | Why? |
| Sequence Analysis, RNA | 1 | 2018 | 2290 | 0.09 | Why? |
| Lymphocyte Count | 1 | 2020 | 4758 | 0.09 | Why? |
| Non-alcoholic Fatty Liver Disease | 1 | 2018 | 907 | 0.09 | Why? |
| Apoptosis | 1 | 2018 | 2335 | 0.09 | Why? |
| Interleukin 1 Receptor Antagonist Protein | 1 | 2016 | 1165 | 0.09 | Why? |
| Plasma | 1 | 2018 | 1809 | 0.09 | Why? |
| Host-Pathogen Interactions | 2 | 2018 | 11041 | 0.08 | Why? |
| Blood Coagulation Disorders | 1 | 2020 | 2040 | 0.08 | Why? |
| Proteomics | 1 | 2018 | 2481 | 0.08 | Why? |
| Immunity | 1 | 2018 | 2651 | 0.08 | Why? |
| Convalescence | 1 | 2017 | 2829 | 0.08 | Why? |
| Serologic Tests | 1 | 2020 | 4359 | 0.08 | Why? |
| Dimerization | 2 | 2009 | 475 | 0.08 | Why? |
| Genomics | 1 | 2018 | 3118 | 0.07 | Why? |
| Enzyme-Linked Immunosorbent Assay | 1 | 2021 | 7868 | 0.07 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2006 | 13720 | 0.07 | Why? |
| Interleukin-6 | 2 | 2020 | 7522 | 0.07 | Why? |
| Drug Design | 1 | 2017 | 2627 | 0.07 | Why? |
| Pandemics | 6 | 2020 | 389249 | 0.07 | Why? |
| Molecular Sequence Data | 3 | 2009 | 3198 | 0.07 | Why? |
| Cell Movement | 2 | 2018 | 695 | 0.07 | Why? |
| Severe Acute Respiratory Syndrome | 2 | 2005 | 12361 | 0.07 | Why? |
| Adenosine Monophosphate | 1 | 2021 | 5652 | 0.06 | Why? |
| Alanine | 1 | 2021 | 5687 | 0.06 | Why? |
| Viral Proteins | 1 | 2002 | 7370 | 0.06 | Why? |
| Fibroblasts | 2 | 2018 | 839 | 0.06 | Why? |
| Oligonucleotide Array Sequence Analysis | 1 | 2004 | 343 | 0.06 | Why? |
| Chloroquine | 1 | 2018 | 3152 | 0.06 | Why? |
| Epidermal Growth Factor | 1 | 2002 | 44 | 0.06 | Why? |
| Prognosis | 2 | 2020 | 32490 | 0.06 | Why? |
| Bronchi | 1 | 2009 | 1048 | 0.06 | Why? |
| COS Cells | 1 | 2002 | 157 | 0.06 | Why? |
| Young Adult | 6 | 2018 | 93724 | 0.06 | Why? |
| Communicable Diseases, Emerging | 1 | 2017 | 2523 | 0.06 | Why? |
| Aged | 8 | 2021 | 215776 | 0.06 | Why? |
| Seroepidemiologic Studies | 1 | 2017 | 10017 | 0.06 | Why? |
| Complement Pathway, Classical | 1 | 2020 | 10 | 0.06 | Why? |
| Prospective Studies | 3 | 2021 | 43301 | 0.06 | Why? |
| Disease Progression | 1 | 2020 | 13580 | 0.05 | Why? |
| Cysteine | 1 | 2002 | 238 | 0.05 | Why? |
| Membrane Glycoproteins | 1 | 2009 | 2273 | 0.05 | Why? |
| Adolescent | 4 | 2018 | 86841 | 0.05 | Why? |
| Age Factors | 2 | 2021 | 21039 | 0.05 | Why? |
| Hypertension | 1 | 2021 | 8895 | 0.05 | Why? |
| Diabetes Mellitus | 1 | 2021 | 8207 | 0.05 | Why? |
| Chemical Phenomena | 1 | 2018 | 22 | 0.05 | Why? |
| Reunion | 1 | 2018 | 94 | 0.05 | Why? |
| Comorbidity | 2 | 2021 | 34796 | 0.05 | Why? |
| Ross River virus | 1 | 2017 | 3 | 0.05 | Why? |
| Gene Expression Regulation, Viral | 1 | 2004 | 925 | 0.05 | Why? |
| RNAi Therapeutics | 1 | 2018 | 35 | 0.04 | Why? |
| Acetophenones | 1 | 2016 | 7 | 0.04 | Why? |
| Neuropathology | 1 | 2018 | 95 | 0.04 | Why? |
| Microsomes, Liver | 1 | 2017 | 96 | 0.04 | Why? |
| Base Sequence | 2 | 2003 | 3581 | 0.04 | Why? |
| Caspase 1 | 1 | 2017 | 149 | 0.04 | Why? |
| Benzopyrans | 1 | 2016 | 39 | 0.04 | Why? |
| Viral Envelope Proteins | 1 | 2009 | 3539 | 0.04 | Why? |
| Epithelial Cells | 1 | 2009 | 3508 | 0.04 | Why? |
| Epidemics | 1 | 2017 | 6407 | 0.04 | Why? |
| Risk Factors | 3 | 2021 | 71621 | 0.04 | Why? |
| Incidence | 1 | 2018 | 25622 | 0.04 | Why? |
| Kinetics | 1 | 2004 | 3238 | 0.04 | Why? |
| Americas | 1 | 2017 | 418 | 0.04 | Why? |
| West Nile virus | 1 | 2017 | 206 | 0.04 | Why? |
| Cardiovascular Diseases | 1 | 2021 | 11497 | 0.04 | Why? |
| Quinazolines | 1 | 2016 | 126 | 0.04 | Why? |
| Interleukin-18 | 1 | 2017 | 328 | 0.04 | Why? |
| Fetal Growth Retardation | 1 | 2017 | 217 | 0.04 | Why? |
| Insect Vectors | 1 | 2017 | 227 | 0.04 | Why? |
| Cytopathogenic Effect, Viral | 1 | 2016 | 635 | 0.03 | Why? |
| Myositis | 1 | 2017 | 185 | 0.03 | Why? |
| DNA, Viral | 1 | 2005 | 2521 | 0.03 | Why? |
| Molecular Structure | 1 | 2018 | 1539 | 0.03 | Why? |
| Protective Factors | 1 | 2018 | 1720 | 0.03 | Why? |
| Conjunctiva | 1 | 2017 | 620 | 0.03 | Why? |
| Seroconversion | 1 | 2021 | 2515 | 0.03 | Why? |
| Sensitivity and Specificity | 2 | 2018 | 22971 | 0.03 | Why? |
| Pregnancy Complications, Infectious | 1 | 2017 | 11559 | 0.03 | Why? |
| Chemokines | 1 | 2017 | 1095 | 0.03 | Why? |
| Aged, 80 and over | 2 | 2018 | 88759 | 0.03 | Why? |
| Membrane Proteins | 1 | 2021 | 1733 | 0.03 | Why? |
| Genetic Variation | 1 | 2005 | 3919 | 0.03 | Why? |
| Endothelial Cells | 1 | 2021 | 2048 | 0.03 | Why? |
| Brazil | 2 | 2018 | 12582 | 0.03 | Why? |
| Hospitalization | 1 | 2021 | 54280 | 0.03 | Why? |
| Asia | 1 | 2017 | 2399 | 0.03 | Why? |
| Limit of Detection | 1 | 2018 | 2698 | 0.02 | Why? |
| Reproducibility of Results | 1 | 2006 | 11304 | 0.02 | Why? |
| Microbial Sensitivity Tests | 1 | 2018 | 2886 | 0.02 | Why? |
| Peptidyl-Dipeptidase A | 1 | 2009 | 9659 | 0.02 | Why? |
| Asymptomatic Diseases | 1 | 2021 | 3444 | 0.02 | Why? |
| Africa | 1 | 2017 | 2986 | 0.02 | Why? |
| Risk Assessment | 1 | 2012 | 25439 | 0.02 | Why? |
| Mutation | 2 | 2009 | 12376 | 0.02 | Why? |
| Arginine | 1 | 2009 | 377 | 0.02 | Why? |
| Enzyme Inhibitors | 1 | 2016 | 1881 | 0.02 | Why? |
| Cohort Studies | 2 | 2021 | 36005 | 0.02 | Why? |
| Diagnostic Tests, Routine | 1 | 2017 | 2643 | 0.02 | Why? |
| Gene Expression Regulation | 1 | 2018 | 4020 | 0.02 | Why? |
| Glycoproteins | 1 | 2009 | 615 | 0.02 | Why? |
| Immunization, Passive | 1 | 2020 | 10067 | 0.02 | Why? |
| Immunoglobulin M | 1 | 2021 | 9091 | 0.02 | Why? |
| Pregnancy Outcome | 1 | 2017 | 3803 | 0.02 | Why? |
| Renal Dialysis | 1 | 2021 | 4358 | 0.02 | Why? |
| Liver | 1 | 2018 | 4007 | 0.02 | Why? |
| RNA, Messenger | 1 | 2017 | 5131 | 0.02 | Why? |
| Case-Control Studies | 1 | 2021 | 17671 | 0.01 | Why? |
| Infectious Disease Transmission, Vertical | 1 | 2017 | 5164 | 0.01 | Why? |
| Mass Spectrometry | 1 | 2005 | 1165 | 0.01 | Why? |
| Real-Time Polymerase Chain Reaction | 1 | 2017 | 11367 | 0.01 | Why? |
| Binding Sites | 1 | 2009 | 6201 | 0.01 | Why? |
| Infant, Newborn | 1 | 2017 | 23105 | 0.01 | Why? |
| Polymorphism, Genetic | 1 | 2003 | 1074 | 0.01 | Why? |
| Vaccination | 1 | 2021 | 19050 | 0.01 | Why? |
| Pregnancy | 1 | 2017 | 23879 | 0.01 | Why? |
| Treatment Outcome | 1 | 2021 | 51732 | 0.01 | Why? |
| Time Factors | 1 | 2017 | 31397 | 0.01 | Why? |
| Disease Transmission, Infectious | 1 | 2017 | 9044 | 0.01 | Why? |
| Global Health | 1 | 2017 | 13911 | 0.01 | Why? |
| Polymorphism, Single Nucleotide | 1 | 2005 | 3607 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2017 | 53120 | 0.01 | Why? |
| Retrospective Studies | 1 | 2021 | 105322 | 0.01 | Why? |
| Child | 1 | 2017 | 70012 | 0.01 | Why? |
| Communicable Disease Control | 1 | 2017 | 29620 | 0.01 | Why? |
| Phylogeny | 1 | 2003 | 13341 | 0.00 | Why? |